Experimental cancer drug shows therapeutic promise in mouse models of multiple sclerosis

An experimental drug originally identified in a National Cancer Institute library of chemical compounds as a potential therapy for brain and basal cell cancers improves the symptoms of mice with a form of the debilitating neurological disorder multiple sclerosis (MS), according to new research.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1OGORis